Skip to main content
Premium Trial:

Request an Annual Quote

Trouble for Elsevier?

Nearly 3,000 researchers, including several winners of the Fields Medal, have signed a petition to boycott scientific publisher Elsevier because of its stance on open-access publishing and journal pricing model, reports ScienceInsider's Jop de Vrieze. The petitioners have pledged not to publish papers in any Elsevier journals, nor do any editorial work or peer review for the company. "The petition, which has created a buzz on researchers' blogs and Twitter, isn't just an attack on Elsevier, its organizers say, but also an attempt to show the scientific community that it can help change the publishing business themselves to increase access to their studies," de Vrieze says. "Many scientists and librarians consider Amsterdam-based Elsevier … one of the villains in the scientific publishing industry; its journals can cost up to $20,000 a year, while the company's profit margin in 2010 was 36%." The company has also received a lot of heat from the scientific community over its support of the Research Works Act, which seeks to limit public access to scientific research.

In a statement to ScienceInsider, Elsevier says its price increases over the past decade have been "among the industry's lowest," and that it has made several attempts to increase access to the studies in its journals.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.